Voyageur Secures Exclusive Rights To One Of The Worlds Rarest Pharmaceutical Minerals, Creating A New Era In Carbon Based Drug Development CALGARY, Alberta, May 11, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce it has signed an LOI with an established...

Voyageur Restructures its ImagingX Joint Venture CALGARY, Alberta, March 20, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (the “Company” or “Voyageur”) is pleased to announce the dissolution of the current joint venture with...

Voyageur Pharmaceuticals Implements Frances Creek Environmental Strategy for Bulk Sample and Future Quarry Production CALGARY, Alberta, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSXV:VM) (the "Company" or "Voyageur") is implementing steps to ensure the Frances Creek barium sulfate project...

Voyageur Pharmaceuticals Confirms Frances Creek Barite Meets all Pharmaceutical Grade Specification CALGARY, Alberta, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSXV:VM) (the "Company" or "Voyageur") is pleased to announce successful test results by SGS Minerals & SGS...